Strategic Blueprint’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Sell
455
-6
-1% -$3.85K 0.01% 559
2025
Q4
$312K Buy
461
+6
+1% +$4.09K 0.02% 516
2025
Q3
$291K Hold
455
0.01% 609
2025
Q2
$244K Buy
+455
New +$218K 0.01% 612
2024
Q4
Sell
-416
Closed -$210K 679
2024
Q3
$210K Buy
416
+1
+0.2% +$486 0.01% 613
2024
Q2
$202K Buy
415
+4
+1% +$2.01K 0.01% 586
2024
Q1
$222K Sell
411
-27
-6% -$14.8K 0.02% 554
2023
Q4
$243K Buy
+438
New +$206K 0.02% 508
2023
Q3
Sell
-638
Closed -$320K 557
2023
Q2
$320K Sell
638
-3
-0.5% -$1.44K 0.03% 405
2023
Q1
$321K Buy
641
+34
+6% +$16.3K 0.03% 395
2022
Q4
$248K Buy
+607
New +$236K 0.03% 443
2022
Q3
Sell
-619
Closed -$217K 510
2022
Q2
$217K Buy
619
+1
+0.2% +$408 0.03% 452
2022
Q1
$338K Sell
618
-7
-1% -$3.68K 0.04% 363
2021
Q4
$412K Sell
625
-4
-0.6% -$2.51K 0.05% 304
2021
Q3
$391K Sell
629
-3
-0.5% -$2.02K 0.06% 280
2021
Q2
$399K Buy
632
+15
+2% +$8.28K 0.06% 262
2021
Q1
$302K Sell
617
-11
-2% -$5.51K 0.06% 242
2020
Q4
$314K Sell
628
-1
-0.2% -$447 0.08% 183
2020
Q3
$247K Buy
+629
New +$233K 0.08% 187
2019
Q4
Sell
-595
Closed -$162K 236
2019
Q3
$162K Buy
+595
New +$166K 0.12% 79

Other funds holding IDXX

Strategic Blueprint's IDXX Position: Q1 2026 in Review

Strategic Blueprint reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q1 2026, selling an estimated $3.85K and leaving 455 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #559.

Strategic Blueprint first reported a position in IDXX in Q3 2019 and has held it in 20 quarters since. The position peaked at $412K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Strategic Blueprint held 455 shares of Idexx Laboratories worth $256K as of Q1 2026.
  • Strategic Blueprint sold 6 Idexx Laboratories shares in Q1 2026, an estimated $3.85K.
  • Idexx Laboratories made up 0.01% of Strategic Blueprint's portfolio in Q1 2026, its #559 holding.
  • Strategic Blueprint first reported a position in Idexx Laboratories in Q3 2019 and has held it in 20 quarters since.
  • Strategic Blueprint's Idexx Laboratories position peaked at $412K in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Strategic Blueprint's 13F filing for Q1 2026, filed 29 Apr 2026.